1. Home
  2. ALZN vs EDBL Comparison

ALZN vs EDBL Comparison

Compare ALZN & EDBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALZN
  • EDBL
  • Stock Information
  • Founded
  • ALZN 2016
  • EDBL 2020
  • Country
  • ALZN United States
  • EDBL United States
  • Employees
  • ALZN N/A
  • EDBL N/A
  • Industry
  • ALZN Medicinal Chemicals and Botanical Products
  • EDBL Farming/Seeds/Milling
  • Sector
  • ALZN Health Care
  • EDBL Consumer Staples
  • Exchange
  • ALZN Nasdaq
  • EDBL Nasdaq
  • Market Cap
  • ALZN 6.1M
  • EDBL 6.8M
  • IPO Year
  • ALZN 2021
  • EDBL 2022
  • Fundamental
  • Price
  • ALZN $0.96
  • EDBL $0.22
  • Analyst Decision
  • ALZN Strong Buy
  • EDBL
  • Analyst Count
  • ALZN 1
  • EDBL 0
  • Target Price
  • ALZN $32.00
  • EDBL N/A
  • AVG Volume (30 Days)
  • ALZN 825.5K
  • EDBL 9.2M
  • Earning Date
  • ALZN 03-24-2025
  • EDBL 03-31-2025
  • Dividend Yield
  • ALZN N/A
  • EDBL N/A
  • EPS Growth
  • ALZN N/A
  • EDBL N/A
  • EPS
  • ALZN N/A
  • EDBL N/A
  • Revenue
  • ALZN N/A
  • EDBL $14,069,000.00
  • Revenue This Year
  • ALZN N/A
  • EDBL $2.43
  • Revenue Next Year
  • ALZN N/A
  • EDBL $42.42
  • P/E Ratio
  • ALZN N/A
  • EDBL N/A
  • Revenue Growth
  • ALZN N/A
  • EDBL 7.88
  • 52 Week Low
  • ALZN $0.92
  • EDBL $0.12
  • 52 Week High
  • ALZN $15.06
  • EDBL $12.47
  • Technical
  • Relative Strength Index (RSI)
  • ALZN 26.54
  • EDBL 47.86
  • Support Level
  • ALZN $0.92
  • EDBL $0.16
  • Resistance Level
  • ALZN $1.15
  • EDBL $0.31
  • Average True Range (ATR)
  • ALZN 0.06
  • EDBL 0.03
  • MACD
  • ALZN -0.01
  • EDBL 0.00
  • Stochastic Oscillator
  • ALZN 13.61
  • EDBL 37.84

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses, together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.

Share on Social Networks: